Company · CIK 1805890

# Fusion Pharmaceuticals Inc.

| CIK | [1805890](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001805890) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | Z4 |
| Business address | Ontario, Canada |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-08-11 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-257653 | Shelf Effective | 2021-07-02 | 2024-06-07 | 4 |
| 333-270604 | Shelf Effective | 2023-03-16 | 2024-06-07 | 3 |
| 333-272713 | Shelf Effective | 2023-06-16 | 2024-06-07 | 3 |
| 333-238968 | IPO Final prospectus | 2020-06-05 | 2020-06-26 | 5 |

## Filings

 16

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-06-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1805890/999999999524001778/9999999995-24-001778-index.htm) Declared effective | 333-272713 | 9999999995-24-001778 |
| 2024-06-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1805890/999999999524001777/9999999995-24-001777-index.htm) Declared effective | 333-270604 | 9999999995-24-001777 |
| 2024-06-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1805890/999999999524001776/9999999995-24-001776-index.htm) Declared effective | 333-257653 | 9999999995-24-001776 |
| 2024-01-19 | [424B5](https://www.sec.gov/Archives/edgar/data/1805890/000119312524011250/0001193125-24-011250-index.htm) Shelf takedown | 333-257653 | 0001193125-24-011250 |
| 2023-06-27 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1805890/999999999523001862/9999999995-23-001862-index.htm) Declared effective | 333-272713 | 9999999995-23-001862 |
| 2023-06-16 | [S-3](https://www.sec.gov/Archives/edgar/data/1805890/000119312523168950/0001193125-23-168950-index.htm) Shelf registered | 333-272713 | 0001193125-23-168950 |
| 2023-03-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1805890/999999999523000645/9999999995-23-000645-index.htm) Declared effective | 333-270604 | 9999999995-23-000645 |
| 2023-03-16 | [S-3](https://www.sec.gov/Archives/edgar/data/1805890/000119312523072555/0001193125-23-072555-index.htm) Shelf registered | 333-270604 | 0001193125-23-072555 |
| 2021-07-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1805890/999999999521002745/9999999995-21-002745-index.htm) Declared effective | 333-257653 | 9999999995-21-002745 |
| 2021-07-02 | [S-3](https://www.sec.gov/Archives/edgar/data/1805890/000119312521207654/0001193125-21-207654-index.htm) Shelf registered | 333-257653 | 0001193125-21-207654 |
| 2020-06-26 | [424B4](https://www.sec.gov/Archives/edgar/data/1805890/000119312520181060/0001193125-20-181060-index.htm) Final prospectus | 333-238968 | 0001193125-20-181060 |
| 2020-06-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1805890/999999999520001543/9999999995-20-001543-index.htm) Declared effective | 333-238968 | 9999999995-20-001543 |
| 2020-06-24 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1805890/000119312520177615/0001193125-20-177615-index.htm) Amendment | 333-238968 | 0001193125-20-177615 |
| 2020-06-22 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1805890/000119312520174636/0001193125-20-174636-index.htm) Amendment | 333-238968 | 0001193125-20-174636 |
| 2020-06-05 | [S-1](https://www.sec.gov/Archives/edgar/data/1805890/000119312520162195/0001193125-20-162195-index.htm) Registration filed | 333-238968 | 0001193125-20-162195 |
| 2020-04-03 | [DRS](https://www.sec.gov/Archives/edgar/data/1805890/000095012320003115/0000950123-20-003115-index.htm) Draft made public | 377-03108 | 0000950123-20-003115 |

[All filings of this company](https://equitycapital.markets/filings?cik=1805890) · [CSV](https://equitycapital.markets/filings.csv?cik=1805890)

---
Source page: https://equitycapital.markets/company/1805890 · Data: U.S. SEC EDGAR · CC BY 4.0